Jump to content

Santosh Kesari: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
m Nearlyevil665 moved page Draft:Santosh Kesari to Santosh Kesari: Publishing accepted Articles for creation submission (AFCH 0.9.1)
Cleaning up accepted Articles for creation submission (AFCH 0.9.1)
Line 1: Line 1:
{{AFC submission|d|bio|u=Seldomgene99|ns=118|decliner=ProClasher97|declinets=20210720171442|ts=20210720170410}} <!-- Do not remove this line! -->

{{AFC comment|1=Most of the sources are simply links to the publications of the subject. And a profile of the subject also isn't exactly considered to be a reliable, secondary source. None of the sources listed here really help to establish the [[WP:N|notability]] of the subject. Also, the "early life and career" section of the article is completely unsourced. [[User:ProClasher97|'''<span style="color:#40E0D0">ProClasher</span><span style="color:#00FF00">9</span><span style="color:#0000FF">7</span>''']] ~ [[User talk:ProClasher97|'''<span style="font-family:'Verdana';color:Maroon">Have A Question? </span>''']] 17:14, 20 July 2021 (UTC)}}

----

{{Short description|Indian American neurologist and neuro-oncologist}}
{{Short description|Indian American neurologist and neuro-oncologist}}


Line 49: Line 43:
{{DEFAULTSORT:Kesari, Santosh}}
{{DEFAULTSORT:Kesari, Santosh}}


[[Category:Neurology]]
{{AfC submission|||ts=20210720181635|u=Seldomgene99|ns=118}}
[[Category:Neuroscience]]
{{DEFAULTSORT:Kesari, Santosh}}
[[Category:Year of birth missing (living people)]]
[[Category:Living people]]

Revision as of 18:19, 20 July 2021

Santosh Kesari
MD, PhD, FANA, FAAN
Born
EducationUniversity of Pennsylvania - School of Arts and Sciences (1992)
University of University of Pennsylvania - PhD degree in molecular biology (1996)
University of Pennsylvania - MD (1999)
Scientific career
FieldsNeurology and neuro-oncology
Thesis Viral therapy for central nervous system neoplasms: Studies using an ICP34.5 deficient herpes simplex virus in murine models [dissertation]. Philadelphia (PA): University of Pennsylvania; 1996.

Santosh Kesari MD, PhD, FANA, FAAN is an Indian-American neuro-oncologist and neurologist[1][2] who currently serves as the Chair and Professor of the Department of Translational Neurosciences and Neurotherapeutics at the Saint John’s Cancer Institute.[3][4][5]

Early life and career

Kesari graduated from the University of Pennsylvania, School of Arts and Sciences in 1992. He received a PhD degree in molecular biology in 1996 and a MD from the University of Pennsylvania, School of Medicine in 1999.[6][7]

Kesari is the Director of Neuro-oncology at Pacific Neuroscience Institute, Providence Saint John’s Health Center and Providence Little Company of Mary Medical Center Torrance.[8][9] He also leads the Pacific Neuroscience Research Center at Pacific Neuroscience Institute.[10]

Kesari is a Fellow of the American Academy of Neurology (FAAN) and of the American Neurological Association (FANA).[11][12]

Scientific work

Kesari's is the author of over 250 scientific publications, reviews, or books whose focus lies in the study of cancer stem cells and their role in the formation of brain tumors and resistance to treatment. His h-index is 73.[13]

Publications

  • Klionsky, Daniel J.; Abdel-Aziz, Amal Kamal; Abdelfatah, Sara; Abdellatif, Mahmoud; Abdoli, Asghar; Abel, Steffen; Abeliovich, Hagai; Abildgaard, Marie H.; Abudu, Yakubu Princely; Acevedo-Arozena, Abraham; Adamopoulos, Iannis E. (2021-01-02). "Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1". Autophagy. 17 (1): 1–382. doi:10.1080/15548627.2020.1797280. ISSN 1554-8627. PMC 7996087. PMID 33634751[14]
  • Wen PY, Kesari S. Malignant gliomas in adults. N Engl J Med. 2008 Jul 31;359(5):492-507. doi: 10.1056/NEJMra0708126. Erratum in: N Engl J Med. 2008 Aug 21;359(8):877. PMID: 18669428.[15]
  • Gabriely, Galina; Wurdinger, Thomas; Kesari, Santosh; Esau, Christine C.; Burchard, Julja; Linsley, Peter S.; Krichevsky, Anna M. (2008-09). "MicroRNA 21 Promotes Glioma Invasion by Targeting Matrix Metalloproteinase Regulators". Molecular and Cellular Biology. 28 (17): 5369–5380. doi:10.1128/MCB.00479-08. ISSN 0270-7306. PMC 2519720. PMID 18591254[16]
  • Norden, A. D.; Young, G. S.; Setayesh, K.; Muzikansky, A.; Klufas, R.; Ross, G. L.; Ciampa, A. S.; Ebbeling, L. G.; Levy, B.; Drappatz, J.; Kesari, S. (2008-03-04). "Bevacizumab for recurrent malignant gliomas: Efficacy, toxicity, and patterns of recurrence". Neurology. 70 (10): 779–787. doi:10.1212/01.wnl.0000304121.57857.38[17]
  • Stupp, Roger; Taillibert, Sophie; Kanner, Andrew A.; Kesari, Santosh; Steinberg, David M.; Toms, Steven A.; Taylor, Lynne P.; Lieberman, Frank; Silvani, Antonio; Fink, Karen L.; Barnett, Gene H. (2015-12-15). "Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial". JAMA. 314 (23): 2535. doi:10.1001/jama.2015.16669. ISSN 0098-7484[18]

References

  1. ^ "Ring's Jamie Siminoff and the Power of Entrepreneurial Thinking". Babson Thought & Action. 2021-04-19. Retrieved 2021-07-20.
  2. ^ "In Conversation: Can mRNA vaccines treat cancer?". www.medicalnewstoday.com. 2021-05-28. Retrieved 2021-07-20.
  3. ^ Miller, Korin (2018-05-08). "'My Runny Nose Turned Out To Be A Brain Leak'". Women's Health. Retrieved 2021-07-20.
  4. ^ Harter, Clara (2021-07-05). "Santa Monica becomes hotbed for cancer fighting biotech industry". Santa Monica Daily Press. Retrieved 2021-07-20.
  5. ^ Reporter, India-West Staff. "Santosh Kesari-led Team Begins Clinical Trials for Treating Brain Tumors Without Chemotherapy". India West. Retrieved 2021-07-17.
  6. ^ "Santosh Kesari, MD, PhD, Neuro-oncology | Pacific Neuroscience Institute - Santa Monica, CA". Pacific Neuroscience Institute. Retrieved 2021-07-20.
  7. ^ "Neuro-Oncologist Santosh Kesari, MD, PhD, Joins UC San Diego". ucsdnews.ucsd.edu. Retrieved 2021-07-20.
  8. ^ "Cancer research: New advances and innovations". www.medicalnewstoday.com. 2021-06-06. Retrieved 2021-07-20.
  9. ^ "Brain Tumor Signs You Should Never Ignore". www.yahoo.com. Retrieved 2021-07-20.
  10. ^ "Aerobic Exercise May Improve Cognitive Function". Healthline. 2021-07-13. Retrieved 2021-07-20.
  11. ^ "Directory Search | American Neurological Association (ANA)". myana.org. Retrieved 2021-07-20.
  12. ^ "Birth Control Risks May Include Brain Cancer". Time. Retrieved 2021-07-20.
  13. ^ "Santosh Kesari". scholar.google.com. Retrieved 2021-07-17.
  14. ^ Klionsky, Daniel J.; Abdel-Aziz, Amal Kamal; Abdelfatah, Sara; Abdellatif, Mahmoud; Abdoli, Asghar; Abel, Steffen; Abeliovich, Hagai; Abildgaard, Marie H.; Abudu, Yakubu Princely; Acevedo-Arozena, Abraham; Adamopoulos, Iannis E. (2021-01-02). "Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1". Autophagy. 17 (1): 1–382. doi:10.1080/15548627.2020.1797280. ISSN 1554-8627. PMC 7996087. PMID 33634751.{{cite journal}}: CS1 maint: PMC format (link)
  15. ^ "Malignant gliomas in adults". scholar.google.com. Retrieved 2021-07-17.
  16. ^ Gabriely, Galina; Wurdinger, Thomas; Kesari, Santosh; Esau, Christine C.; Burchard, Julja; Linsley, Peter S.; Krichevsky, Anna M. (2008-09). "MicroRNA 21 Promotes Glioma Invasion by Targeting Matrix Metalloproteinase Regulators". Molecular and Cellular Biology. 28 (17): 5369–5380. doi:10.1128/MCB.00479-08. ISSN 0270-7306. PMC 2519720. PMID 18591254. {{cite journal}}: Check date values in: |date= (help)CS1 maint: PMC format (link)
  17. ^ Norden, A. D.; Young, G. S.; Setayesh, K.; Muzikansky, A.; Klufas, R.; Ross, G. L.; Ciampa, A. S.; Ebbeling, L. G.; Levy, B.; Drappatz, J.; Kesari, S. (2008-03-04). "Bevacizumab for recurrent malignant gliomas: Efficacy, toxicity, and patterns of recurrence". Neurology. 70 (10): 779–787. doi:10.1212/01.wnl.0000304121.57857.38. ISSN 0028-3878.
  18. ^ Stupp, Roger; Taillibert, Sophie; Kanner, Andrew A.; Kesari, Santosh; Steinberg, David M.; Toms, Steven A.; Taylor, Lynne P.; Lieberman, Frank; Silvani, Antonio; Fink, Karen L.; Barnett, Gene H. (2015-12-15). "Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial". JAMA. 314 (23): 2535. doi:10.1001/jama.2015.16669. ISSN 0098-7484.